Kardium clinches $340M CAD to commercialize its heart-mapping tech for atrial fibrillation
BC-based Kardium has secured $340 million CAD (approximately $250 million USD) to support the global launch of its flagship product: the Globe Pulsed Field System, a device designed to treat atrial fibrillation (AF).

The best Articles in our Network